The second phase trial on average showed that patients administered with the drug recovered 2.5 days earlier than other patients. (Representative image) An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose (2-DG) has been given emergency approval by the Drug Controller General of India (DCGI) for Coronavirus patients in the country. The drug, which was … Read more
Representative image After an outcry for remdesivir, there is now yet another experimental anti-viral drug – Molnupiravir to deal with COVID patients. Hyderabad-headquartered Natco Pharma on Monday, April 26th, disclosed to the bourses that it has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of Phase-III clinical trial of Molnupiravir … Read more
The volunteer had also sought the compensation worth Rs 5 crore from the vaccine manufacturer and requested the authorities to stop the clinical trials of the vaccine. World’s largest vaccine manufacturer Serum Institute of India has said that the Coronavirus vaccine candidates developed by the University of Oxford and AstraZeneca is 100 percent safe and … Read more
Scientists are also measuring how the membrane reacts when it is exposed to either melatonin or azithromycin which are being investigated as possible treatments of Coronavirus. Even as a couple of Coronavirus vaccine candidates have claimed over 90 percent efficacy in preventing the spread of Coronavirus, scientists are exploring other treatment and preventive care options … Read more
However, drugmaker Pfizer, which is reported to be at the forefront of releasing the joint statement, has itself been excited to release the vaccine at an early date. Even as governments in different countries are willing to ease the regulatory guidelines for approval of a COVID-19 vaccine in order to speed up a public launch, … Read more